EarningsQ2 2024 Earnings Report

Royalty Pharma (RPRXN) Q2 2024 Earnings Report

1 Followers

MX:RPRXN Q2 2024 EPS Results

Actual EPS$17.70

Consensus EPS$17.77

Beat/MissMissed by -$0.07

One Year Ago EPS$15.56

Actual Revenue$9.89B

Expected Revenue$11.55B

Beat/MissMissed by -$1.66B

YoY Revenue Growth-0.17%

QuarterQ2 2024

Date08/08/2024

TimeBefore Open

Conference CallThursday, August 8, 2024

MX:RPRXN Upcoming Earnings

Royalty Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:RPRXN Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	21.75 / -	21.6	―
Aug 05, 2026	2026 (Q2)	23.44 / 24.33	21.011	15.78% (+3.31)
May 06, 2026	2026 (Q1)	22.35 / 23.86	13.792	73.03% (+10.07)
Feb 11, 2026	2025 (Q4)	23.68 / 27.00	21.195	27.37% (+5.80)
Nov 05, 2025	2025 (Q3)	18.30 / 21.60	16.886	27.92% (+4.71)
Aug 06, 2025	2025 (Q2)	19.00 / 21.01	17.696	18.73% (+3.31)
May 08, 2025	2025 (Q1)	17.55 / 13.79	18.009	-23.42% (-4.22)
Feb 11, 2025	2024 (Q4)	19.43 / 21.19	21.158	0.17% (+0.04)
Nov 06, 2024	2024 (Q3)	17.07 / 16.89	14.529	16.22% (+2.36)
Aug 08, 2024	2024 (Q2)	17.77 / 17.70	15.56	13.73% (+2.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed